“new-england-journal-of-medicine” Archives

in
Entry Author Date Location
Bio Roundup: Moderna Publishes, Life Science Cash, AdComm Votes & More 07/17/20 National
Moderna Publishes Early COVID-19 Vaccine Data, Preps for Phase 3 Test 07/15/20 Boston
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone 09/06/19 National
SMA, Migraine Data Lead Neuro Highlights from AAN Meeting 05/07/19 National
How an Ohio Kids’ Hospital Quietly Became Ground Zero for Gene Therapy 04/15/19 National
Genetic Medicine: FDA OKs 2nd Cancer Drug That Targets DNA, Not Tissues 11/26/18 National
Eyeing Approval, Pfizer Touts Tafamidis Study, but Details Lacking 08/27/18 New York
Eli Lilly’s Arthritis Drug Approved at Lower Dose with Boxed Warning 06/01/18 Indiana
FDA Panel Splits on Lilly Arthritis Drug, Backs Lower of Two Doses 04/23/18 Indiana
Bio Roundup: Hope for Lungs, Bradner’s Complaint, FDA Nods & More 04/20/18 National
Safety Concerns Linger for Lilly’s Arthritis Drug as FDA Panel Looms 04/19/18 Indiana
For More Lung Cancer Patients, the Promise of No Chemo Looms Larger 04/16/18 National
Bio Roundup: CMS Backs Cancer Tests, Right to Try Passes, AbbVie Sinks 03/23/18 National
Solid Discloses Duchenne Problems in IPO & Raises Rival’s Hackles 01/25/18 Boston
Xconomy Bookclub: “Troublemakers” Charts the Birth of Silicon Valley 01/05/18 National
Bio Roundup: Trials to Watch, Mega Deals, Video Game Therapy & More 12/08/17 Boston
Bio Roundup: Migraine Data, Cancer Drug Combos, Azar Hearing & More 12/01/17 National
With Good Data From Rival Migraine Drugs, Doctors Foresee Price Headaches 11/29/17 San Francisco
Biotech Roundup: Opioid News, ASH Preview, Boston Bio IPOs & More 11/03/17 National
Eli Lilly Preps Rejected Rheumatoid Arthritis Drug for Resubmission 08/30/17 Indiana
Will Merck Seek FDA Filing For Heart Drug After Lackluster Results? 08/29/17 New York
Portola Pharmaceuticals’ Drug to Prevent Blood Clots Wins FDA Nod 06/23/17 San Francisco
Bio Roundup: Trumpcare Is Mean, SCOTUS Says Go, Merck’s Myeloma No 06/16/17 National
With $145M Buyout, River Vision’s Plan For Stalled Roche Drug Pays Off 05/08/17 New York
FDA Nixes Lilly, Incyte RA Drug, Seeks More Dosing and Safety Data 04/14/17 Indiana
With Fresh Pneumonia Data, Paratek To Seek 2018 Antibiotic Approval 04/03/17 Boston
With New Data, Amgen Promises Refund If Cholesterol Drug Doesn’t Work 03/17/17 San Francisco
Despite FDA Delay, Advocates Hopeful for New Genentech MS Drug 12/21/16 San Francisco
War, Surgery, and Cancer Vaccines: Meet San Antonio’s George Peoples 08/19/16 Texas
After Zafgen Abandons Prader-Willi Drug, Could Rhythm Offer Hope? 07/28/16 Boston
Page 1 of 3 next page »